Simple logistics—availability, childcare, and time—stop some Latinas and other women of color from volunteering for breast cancer clinical trials, according to a new survey. The survey, led by For The Breast of Us, an online breast cancer survivor community, and Sommer Consulting, found that the anticipated time demands of a clinical trial may appear "too intimidating." Most women of color struggle with multiple demands in their lives. The perceived or real logistics of participating in a clinical trial could make it harder. One respondent said: “You still have to worry about how am I going to run my household, especially as a woman of color, who typically a lot of times are single-family or single-parent households." "The results of this survey demonstrate how ...
Are you Latino? Have you participated in a clinical trial related to cancer, Alzheimer’s, or another condition? If so, we want to talk with you and share your story! Salud America! is looking to interview and write stories about heroes like you — Latinos who have participated in a clinical trial — to showcase the benefits of volunteering to inspire other Latinos to volunteer, too. Dr. Amelie G. Ramirez’s Salud America! program at UT Health San Antonio is sharing the stories of clinical trial heroes with the support of Genentech, a member of the Roche Group. “Clinical trials are studies that help researchers learn more and more to help slow, manage, and treat Alzheimer's and cancer,” Ramirez said. “Clinical trials help us fight for our familia.” To share ...
Today, the National Institute on Aging (NIA) of the National Institutes of Health (NIH) designated UT Health San Antonio and UT Texas Rio Grande Valley as an Alzheimer’s Disease Research Center to boost research and reduce the Alzheimer's burden among Latinos, who suffer disparities in dementia. The new center is the first in South Texas. It joins 32 other centers nationwide that are accelerating research on effective Alzheimer’s and dementia prevention, diagnostics, and treatments, and improving support for families and caregivers. Salud America! is a center partner to promote its research and clinical trials. "This federal designation by NIA will be transformational as we seek cures and provide the best possible care, based on the most up-to-date knowledge and technology, ...
Sadly, Latinos are 1.5 times more likely to develop Alzheimer’s disease than whites. Across the board, Latinos are underrepresented in clinical research. Without Latino representation in Alzheimer's clinical trials, researchers cannot find treatments that work best for this population. Researchers also must understand and address the differential role of Alzheimer's among Latinos, and the impact of alcohol, sleep deprivation, diabetes, and more. Let’s use #SaludTues on Tuesday, Oct. 5, 2021, to tweet about the latest research and beneficial strategies and clinical trials to reduce Alzheimer's disease and promote better brain health among Latinos and all people! WHAT: #SaludTues: Importance of Latino Participation in Clinical Trials in Alzheimer’s Disease
TIME/DATE: ...
Combat COVID is a federal education initiative to share bilingual information and tips about vaccines, potential treatments, and clinical trials for COVID-19. A clinical trial is a research study to find a new treatment or achieve a better understand a disease. In the case of COVID-19, which has overly burdened Latinos and Blacks, clinical trials need more participants of color to ensure that COVID-19 treatments are effective for everyone. "Clinical trials are at the heart of many medical discoveries," according to the team at Combat COVID, run by the U.S. Department of Health and Human Services. "[Trials] are the key to protecting our communities now and in the future." Let's take a look at the work Combat COVID is doing.
Promoting Clinical Trails for COVID-19
Combat COVID ...
Breast cancer is the leading cause of death in Latinas. Systemic health inequities contribute to lower rates of breast cancer screening among Latinos, which leads to cancer diagnoses at later disease stages. This is why we're sharing Susan G. Komen’s 2021 ongoing webinar series on metastatic breast cancer (MBC)! The next two webinars, "MBC in the Hispanic/Latino Community," are set for 6 p.m. CT Sept. 23, 2021, in English and 6 p.m. CT Sept. 30, 2021, in Spanish. Panelists are: Dr. Filipa Lynce, Dana-Farber Cancer Institute, Director, Inflammatory Breast Center, Harvard Medical School.
Dr. Jose Pablo Leone, Dana-Farber Cancer Institute, Director, Program for Breast Cancer in Men, Harvard Medical School Panelists will foster a safe, collaborative space to discuss ...
Cancer is a tough, scary, life-threatening journey, especially for women of color. That is why researchers conduct clinical trials, which are studies to find more effective treatments or achieve a better understand breast cancer and survival among minorities. But, to make progress, clinical trials need diverse volunteers – like Elsada Wilson. Wilson joined a clinical trial at Mays Cancer Center at UT Health San Antonio and found hope for herself, her family, and the future. “I felt like I was helping further studies and knowledge,” she said. "If it helps me then I'll be able to help my family and help other people that need help. I wanted to help others. I said to myself, ‘It might be that small thing that might help another person.’ Right?”
Wilson’s Breast ...
Latinos are 1.5 times more likely to develop Alzheimer’s than their white peers. Its why diversity in clinical trials is absolutely critical. Fortunately, those studies can help us fight back against Alzheimer’s. If you are age 55 to 80, you can volunteer for the AHEAD Clinical Trial that aims to protect against the onset of Alzheimer's disease, led by the experts at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio. “I got involved with the AHEAD clinical trial because both of my parents had Alzheimer’s,” Dave Ralberer, an AHEAD study participant and study partner, said. “My mother was 72 when she passed away. My dad has been struggling with the disease for 13 years. I have the unusual opportunity to be working with ...
El cáncer es un camino difícil, miedoso y peligroso para la vida, especialmente para las mujeres de color. Por esto es que los investigadores realizan estudios clínicos, que son estudios para encontrar tratamientos más efectivos o para lograr un mejor entendimiento del cáncer de seno y la supervivencia en las minorías. Pero, para progresar, los estudios clínicos necesitan voluntarios diversos, como Elsada Wilson. Wilson participó en un estudio clínico del Mays Cancer Center de UT Health San Antonio y encontró esperanza para ella, su familia y el futuro. "Sentí que estaba ayudando a avanzar los estudios y el conocimiento", dijo. "Si me ayuda, entonces podré ayudar a mi familia y ayudar a otras personas que necesitan ayuda. Quería ayudar a los demás. Me dije a mí ...
